Education
About Us
Working with TipRanks
Follow Us
Mangalam Drugs & Organics Ltd. (IN:MANGALAM)
:MANGALAM
Total Valuation
Mangalam Drugs & Organics Ltd. has a market cap or net worth of ₹1.43B. The enterprise value is ₹2.48B.
Market Cap₹1.43B
Enterprise Value₹2.48B
Share Statistics
Mangalam Drugs & Organics Ltd. has 15,828,248 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding15,828,248
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Mangalam Drugs & Organics Ltd.’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 4.41%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)4.41%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee7.35M
Profits Per Employee155.57K
Employee Count432
Asset Turnover0.87
Inventory Turnover1.21
Valuation Ratios
The current PE Ratio of Mangalam Drugs & Organics Ltd. is 18.51. Mangalam Drugs & Organics Ltd.’s PEG ratio is -1.31.
PE Ratio18.51
PS Ratio0.00
PB Ratio1.02
Price to Fair Value0.84
Price to FCF13.36
Price to Operating Cash Flow3.92
PEG Ratio-1.31
Income Statement
In the last 12 months, Mangalam Drugs & Organics Ltd. had revenue of 3.18B and earned 67.21M in profits. Earnings per share was 4.25.
Revenue3.18B
Gross Profit1.50B
Operating Income192.16M
Pretax Income47.86M
Net Income67.21M
EBITDA358.23M
Earnings Per Share (EPS)4.25
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Mangalam Drugs & Organics Ltd. pays an annual dividend of ₹0.5, resulting in a dividend yield of ―
Dividend Per Share₹0.5
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.11
52-Week Price Change-19.24%
50-Day Moving Average80.57
200-Day Moving Average98.83
Relative Strength Index (RSI)76.27
Average Volume (3m)5.10K
Important Dates
Mangalam Drugs & Organics Ltd. upcoming earnings date is Aug 7, 2025, TBA (Confirmed).
Last Earnings DateMay 17, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend DateDec 21, 2017
Financial Position
Mangalam Drugs & Organics Ltd. as a current ratio of 1.04, with Debt / Equity ratio of 54.15%
Current Ratio1.04
Quick Ratio0.31
Debt to Market Cap0.71
Net Debt to EBITDA2.61
Interest Coverage Ratio1.29
Taxes
In the past 12 months, Mangalam Drugs & Organics Ltd. has paid 19.35M in taxes.
Income Tax19.35M
Effective Tax Rate0.40
Enterprise Valuation
Mangalam Drugs & Organics Ltd. EV to EBITDA ratio is 6.09, with an EV/FCF ratio of 9.74.
EV to Sales0.69
EV to EBITDA6.09
EV to Free Cash Flow9.74
EV to Operating Cash Flow5.12
Balance Sheet
Mangalam Drugs & Organics Ltd. has ₹25.89M in cash and marketable securities with ₹962.30M in debt, giving a net cash position of ₹936.41M billion.
Cash & Marketable Securities₹25.89M
Total Debt₹962.30M
Net Cash₹936.41M
Net Cash Per Share₹59.16
Tangible Book Value Per Share₹74.08
Margins
Gross margin is 32.29%, with operating margin of 6.05%, and net profit margin of 2.12%.
Gross Margin32.29%
Operating Margin6.05%
Pretax Margin1.51%
Net Profit Margin2.12%
EBITDA Margin11.28%
EBIT Margin6.05%
Analyst Forecast
The average price target for Mangalam Drugs & Organics Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-13.66%
EPS Growth Forecast―